Amondys 45 100 mg/2 mL (50 mg/mL) injection Images
Generic Name: casimersen
This medication has been identified as Amondys 45 100 mg/2 mL (50 mg/mL) injection. It is supplied by Sarepta Therapeutics, Inc.
Amondys 45 is used in the treatment of Duchenne Muscular Dystrophy and belongs to the drug class miscellaneous uncategorized agents. Amondys 45 100 mg/2 mL (50 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Amondys 45
- Generic Name
- casimersen
- Strength
- 100 mg/2 mL (50 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous uncategorized agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sarepta Therapeutics, Inc.
- National Drug Code (NDC)
- 60923-0227
See also:
Vyondys 53
Vyondys 53 is used for Duchenne muscular dystrophy (DMD) in children and young adults with a ...
Exondys 51
Exondys 51 is used for Duchenne Muscular Dystrophy (DMD) in children and young adults with a ...
Elevidys
Elevidys is a gene therapy for Duchenne muscular dystrophy, that is given as a one-time infusion ...
Agamree
Agamree (vamorolone) is an FDA-approved treatment for Duchenne muscular dystrophy (DMD) to improve ...
Duvyzat
Duvyzat (givinostat) is used to treat Duchenne muscular dystrophy (DMD) to delay symptoms and ...
Emflaza
Emflaza (deflazacort) is a corticosteroid medication used to treat a rare genetic disorder called ...
More about Amondys 45 (casimersen)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous uncategorized agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.